GAS6 and myeloid sarcoma: Although the microglial expression of GAS6 under healthy conditions is lower in humans than in mice, descriptive studies showed that MS patients with a higher GAS6 concentration in the cerebrospinal fluid (CSF) underwent shorter and less severe MS flares (28).